Tobias Arkenau

Consultant Medical Oncologist, HCA Healthcare
Ellipses Pharma, UK
Professor Tobias Arkenau is a renowned Consultant Medical Oncologist with HCA Healthcare and is practicing at numerous locations including The LOC, The Harley Street Clinic, The Princess Grace, and The Wellington Hospital. He is also serving as a Chief Medical Officer and Global Head of Drug Development at Ellipses Pharma, a London-based biotech focusing on cancer drug development.
He was founding Medical Director of the Sarah Cannon Research Institute UK and Clinical Lead for the HCA Healthcare UK Cancer Service Line. He is holding an honorary Professorship at University College London Hospital.
Prof Arkenau has a wide range of experience in a variety of cancers, particularly gastrointestinal and skin cancers. He was awarded his medical degree from Hannover Medical School in Germany in 2000. Following this, he completed his specialist training in oncology across numerous centres of excellence including the Royal Marsden Hospital. He was awarded a Fellowship by the Royal College of Physicians, and he is a key opinion leader in his field of Gastrointestinal Cancers, Drug Development and Immunotherapy for his research contributions to his field. During his career, he has published numerous peer reviewed articles and book chapters and contributes regularly at international meetings such as ASCO, ESMO and AACR.

Events/Masterclasses Tobias Arkenau is currently speaking at

Finance

Life & Health Insurance Summit
15 – 16 May 2024
Mercure Amsterdam City Hotel, The Netherlands
Life & Health Insurance Summit - the great reset to endure and flourish in the years ahead.

Are you interested in a custom-made event with this trainer?

Contact us to Request more information about your custom-made Corporate Learning program.

REQUEST MORE INFORMATION

Tobias Arkenau
Consultant Medical Oncologist, HCA Healthcare
Ellipses Pharma, UK
Professor Tobias Arkenau is a renowned Consultant Medical Oncologist with HCA Healthcare and is practicing at numerous locations including The LOC, The Harley Street Clinic, The Princess Grace, and The Wellington Hospital. He is also serving as a Chief Medical Officer and Global Head of Drug Development at Ellipses Pharma, a London-based biotech focusing on cancer drug development.
He was founding Medical Director of the Sarah Cannon Research Institute UK and Clinical Lead for the HCA Healthcare UK Cancer Service Line. He is holding an honorary Professorship at University College London Hospital.
Prof Arkenau has a wide range of experience in a variety of cancers, particularly gastrointestinal and skin cancers. He was awarded his medical degree from Hannover Medical School in Germany in 2000. Following this, he completed his specialist training in oncology across numerous centres of excellence including the Royal Marsden Hospital. He was awarded a Fellowship by the Royal College of Physicians, and he is a key opinion leader in his field of Gastrointestinal Cancers, Drug Development and Immunotherapy for his research contributions to his field. During his career, he has published numerous peer reviewed articles and book chapters and contributes regularly at international meetings such as ASCO, ESMO and AACR.
Tobias Arkenau
Description